SEC Form D filing
Kaida BioPharma Inc., 2026-01-21
An SEC Form D private-offering notice from Fort Lauderdale, FL, a $4,100,507 filer-stated offering target in Biotech. Filed 2026-01-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Kaida BioPharma Inc. Verified via SEC Form D
Filed 2026-01-21Filed to raise $4,100,507First money in 2023-10-24Raised so far $1,600,507HQ (as filed) Fort Lauderdale, FLSector Biotech machine-classified from the filing aloneStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Bernard, Inc., 2026-01-21, $500K, Saint Augustine, FL
- Proxima Bio, Inc., 2026-01-21, $91.5M, New York, NY
- Coastal Concierge Technologies, Inc, 2026-01-21, Sarasota, FL
- Caldera Therapeutics, Inc., 2026-01-21, $37.5M, Cambridge, MA
- Permit Rockstar, Inc., 2026-01-21, $2M, Jacksonville, FL
- Cantai Therapeutics, Inc., 2026-01-21, $3M, Philadelpia, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.